Researchers at the Max Planck Institute for Molecular Genetics have developed a novel synthetic micropeptide termed the ...

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Antibody Fragments Market Share, Size, Trends, Industry Analysis Report, By Specificity, By Type, By Therapy, By ...

ITHACA, N.Y. -- A novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicated gastric cancer in treated mice, a multi-institutional ...

These fragments, called variable domains, are the business end of any antibody — they act as the antibody’s “sensor” and can stick to parts of pathogens or toxins, whatever substance is ...

A new study from Karolinska Institutet shows how a small antibody fragment can block fertilization by targeting a key protein on the surface of the egg. This discovery brings a non-hormonal ...

(Nanowerk News) A novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicated gastric cancer in treated mice, a multi-institutional team of ...

Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Antibody Fragments Market Share, Size, Trends, Industry Analysis Report, By Specificity, By Type, By Therapy, By Application, By Region, Segment Forecast ...

Our study shows how a small antibody fragment can block fertilization by targeting ZP2, a key protein in the outer layer of the egg that is involved in both sperm binding and blocking polyspermy." ...